...
首页> 外文期刊>Liver international : >Hepatocellular carcinoma appearance in patients with hepatitis C virus-related chronic liver disease 90 and 70 months after sustained virological response to interferon and ribavirin.
【24h】

Hepatocellular carcinoma appearance in patients with hepatitis C virus-related chronic liver disease 90 and 70 months after sustained virological response to interferon and ribavirin.

机译:在持续对干扰素和病毒唑进行病毒学应答后90和70个月,患有丙型肝炎病毒相关的慢性肝病的患者出现肝细胞癌。

获取原文
获取原文并翻译 | 示例

摘要

We report here two cases of hepatocellular carcinoma (HCC) 90 and 70 months, respectively, after successful treatment with interferon (IFN) and ribavirin for hepatitis C virus (HCV)-related cirrhosis. A 50-year-old Caucasian man and a 66-year-old Caucasian woman with HCV-related cirrhosis were treated with IFN and ribavirin and in both cases a sustained virological response (SVR) was obtained with persistent normalization of serum aminotransferases and continuous disappearance of serum HCV-RNA. Both patients were subsequently followed up within an HCC surveillance programme based on biochemical and ultrasound (US) evaluation every 6 months and the appearance of HCC was detected 90 and 70 months, respectively, after discontinuation of therapy. We introduce these two cases to call attention to the importance of not underestimating the risk of HCC development even many years after complete HCV eradication, especially in the presence of established cirrhosis and concomitance of other risk factors for HCC.
机译:我们在这里分别报告成功治疗干扰素(IFN)和利巴韦林治疗丙型肝炎病毒(HCV)相关性肝硬化的两个肝细胞癌(HCC)分别为90和70个月。用干扰素和利巴韦林治疗了HCV相关性肝硬化的50岁高加索男人和66岁高加索女人,并且在两种情况下均获得了持续的病毒学应答(SVR),血清转氨酶持续正常化并持续消失血清HCV-RNA。两名患者随后每6个月接受一次基于生化和超声(US)评估的HCC监测计划,在停止治疗后分别于90和70个月检测到HCC的出现。我们介绍这两个案例,以提醒人们注意即使完全消除HCV后也要低估HCC发生风险的重要性,尤其是在存在已确定的肝硬化和其他HCC危险因素的情况下。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号